ClinicalTrials.gg
CompletedNCT00640055VAUpdated Jul 31, 2014

Verbal Autopsy to Assess Early Neonatal Death and Stillbirth

A Phase 4 interventional study of Coordinator and Physician-assigned cause of death in Perinatal Mortality, Cause of Neonatal Death and Cause of Stilbirth, sponsored by NICHD Global Network for Women's and Children's Health. Completed at 4 sites in 4 countries. Open to participants aged Up to 7 Days, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-07-31.

Sponsored by NICHD Global Network for Women's and Children's Health · Phase 4, Interventional, and Diagnostic

Phase
Phase 4
Study type
Interventional
Enrollment
200
Allocation
Non-randomized
Ages
Up to 7 Days
Sex
All
01

Study summary

The NICHD Global Network (GN) for Women's and Children's Health Research, a multi-site, international research network, provides a unique infrastructure to implement an expanded perinatal verbal autopsy study using the FIRST BREATH trial as its platform. The FIRST BREATH trial is an ongoing study of neonatal resuscitation training in rural community settings within Global Network sites in Central Africa, Asia and Latin America.

This study uses a validated VA questionnaire to determine COD of stillbirths and early neonatal deaths among participants in the FIRST BREATH study. We propose to expand the usefulness of perinatal verbal autopsy methodology in two ways. First by assessing whether the Community Coordinator (a non-physician health worker) can assign COD with a high level of concordance comparable to a Physician Panel, and second, whether the FIRST BREATH Birth Attendant can provide as reliable perinatal information as the mother during the VA interview. Our primary hypothesis is that the COD assigned by the FIRST BREATH Community Coordinator will be the same as the COD assigned by the Physician Panel in greater than 70% of early neonatal deaths (ENDs), when both use the same VA and FIRST BREATH data.

02

Conditions studied

  • Perinatal Mortality
  • Cause of Neonatal Death
  • Cause of Stilbirth

Keywords

  • verbal autopsy
  • stillbirth
  • neonatal death
03

In context

Perinatal Death

120 studies on the registry are indexed under Perinatal Death; 25 are open to participants now.

This study's planned enrollment of 200 is below the median of 427 across 84 interventional studies indexed under Perinatal Death.

Browse Perinatal Death studies →

Lead sponsor

NICHD Global Network for Women's and Children's Health is the lead sponsor of 33 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 7 Days
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Neonatal death with 7-days or stillbirth
  • Lives in study cluster

Exclusion criteria

Exclusion Criteria:

  • Mother died
  • Delivery in hospital setting
05

Study design

Phase
Phase 4
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Single group
Masking
Double (Participant, Care provider)
Enrollment
200 participants (estimated)

Study arms

  • Active comparator
    1

    Coordinator (non-physician)

    Other: Coordinator

  • Placebo comparator
    2

    Physician

    Other: Physician-assigned cause of death

Interventions

  • OtherCoordinator

    Coordinator (non-physician) assigned cause of death

  • OtherPhysician-assigned cause of death

    Physician (gold standard) cause of death

06

What researchers measure

Primary outcomes

  1. Cause of death as assigned by a Community Coordinator compared to the cause of death assigned by the physician panel

    Time frame: 7-days

Secondary outcomes

  1. The COD for stillbirth as assigned by the Community Coordinator compared to the COD for stillbirth as assigned by the Physician Panel

    Time frame: 7 days

  2. The agreement between mothers' and birth attendants' responses on selected items on the VA questionnaire (considering the mothers' response as the reference standard).

    Time frame: 7 days

07

Study locations

4 sites
  • Kinshasa School of Public Health
    Kinshasa, Congo
  • San Carlos University
    Guatemala City, Guatemala
  • Aga Khan University
    Karachi, Pakistan
  • University of Zambia
    Lusaka, Zambia
08

References and documents

Related links

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jul 2007, a primary completion of May 2008 and a completion of Jul 2008. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 18, 2008
First posted
Mar 20, 2008
Start
Jul 2007
Primary completionActual
May 2008
CompletionActual
Jul 2008
Last update
Jul 31, 2014
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 31, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00640055
Lead sponsor
NICHD Global Network for Women's and Children's Health
Responsible party
Sponsor
First posted
Mar 20, 2008
Start date
Jul 2007
Primary completion
May 2008
Completion
Jul 2008
Last update
Jul 31, 2014

Study contacts

Marion Koso-Thomas, MD
study director · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Cyril Engmann
principal investigator · UNC at CHapel Hill

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion